The five founders of CoreRx have developed an international reputation for being on the leading edge, in the design and implementation of novel pharmaceutical formulations for many of the world’s most renowned innovator, generic, and virtual pharmaceutical companies for more than a decade. The founders, Brian McMillan, Jim Davis, Rob Trivedi, Mark Licarde, and Dr. Todd Daviau were the core management team at their former CRO company.

Their focus and expertise has enabled clients to realize an advantage and capitalize on the burgeoning pharmaceutical market over the last several years. The five founders average more than 15 years of pharmaceutical development experience. CoreRx will have the capabilities for developing all dosage forms (tablets, capsules, liquids, gels, creams, etc…) in meeting the needs of the clients in the pharmaceutical industry. (more…)